Press "Enter" to skip to content

New patent expiration for Sunovion Resp drug LONHALA MAGNAIR KIT

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Sunovion Resp drug LONHALA MAGNAIR KIT

Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT
Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT

Lonhala Magnair Kit is a drug marketed by Sunovion Resp and is included in one NDA. It is available from two suppliers. There are twelve patents protecting this drug.

This drug has eigthy-five patent family members in thirteen countries.

The generic ingredient in LONHALA MAGNAIR KIT is glycopyrrolate. Two suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Sunovion Resp drug LONHALA MAGNAIR KIT

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!